ATRA- Atara Biotherapeutics, Inc.

Name: Atara Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Atara Biotherapeutics, Inc. (ATRA) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Panacea Innovation Ltd	1.32M	$11.05M	-
10%	Adiumentum Capital Fund I LP	377.2K	$3.15M	-
CEO	Nguyen Anhco	143.1K	$1.19M	-
?	Touchon Pascal	78.0K	$650.1K	-
Other	Grant-Huerta Yanina	52.0K	$434.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 2, 2023	Touchon Pascal82	President And CEO	Sell	15,679	$3.63	$56,867.73	-2.0%	-57.3%	-78.5%
Mar 2, 2023	Murugan Amar80	SVP, GC &Secretary	Sell	4,221	$3.63	$15,309.57	-1.5%	-57.3%	-78.5%
Mar 2, 2023	Koppikar Utpal76	Chief Financial Officer	Sell	6,871	$3.63	$24,921.12	-3.6%	-57.3%	-78.5%
Mar 2, 2023	Dupont Jakob88	EVP, Head Of R&D	Sell	5,074	$3.63	$18,403.40	-1.7%	-57.3%	-78.5%
Feb 7, 2023	Koppikar Utpal76	Chief Financial Officer	Sell	2,485	$5.46	$13,568.10	-1.3%	-45.6%	-81.8%
Nov 16, 2022	Dupont Jakob88	EVP, Head Of R&D	Sell	4,342	$4.49	$19,496.70	-1.4%	+1.5%	-89.5%
Nov 16, 2022	Touchon Pascal82	President And CEO	Sell	15,591	$4.49	$70,003.59	-3.4%	+1.5%	-89.5%
Nov 16, 2022	Murugan Amar80	SVP, GC &Secretary	Sell	3,612	$4.49	$16,217.88	-2.8%	+1.5%	-89.5%
Nov 16, 2022	Koppikar Utpal76	Chief Financial Officer	Sell	6,255	$4.49	$28,086.03	-1.6%	+1.5%	-89.5%
Aug 16, 2022	Murugan Amar80	SVP, GC &Secretary	Sell	3,430	$5.03	$17,268.85	-1.3%	+4.9%	-65.8%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC